Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome.

Shaw AD, Schermer CR, Lobo DN, Munson SH, Khangulov V, Hayashida DK, Kellum JA
Crit Care. 2015 19: 334

PMID: 26370823 · PMCID: PMC4570151 · DOI:10.1186/s13054-015-1045-z

MeSH Terms (17)

Adolescent Adult Aged Aged, 80 and over Crystalloid Solutions Female Fluid Therapy Humans Infusions, Intravenous Isotonic Solutions Length of Stay Male Middle Aged Severity of Illness Index Systemic Inflammatory Response Syndrome Treatment Outcome Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: